Current Report Filing (8-k)
December 31 2020 - 04:20PM
Edgar (US Regulatory)
0000051143 false Capital stock, par
value $.20 per share IBM CHX 0000051143 2020-12-24 2020-12-24
0000051143 us-gaap:CommonStockMember exch:XCHI 2020-12-24
2020-12-24 0000051143 us-gaap:CommonStockMember exch:XNYS
2020-12-24 2020-12-24 0000051143 ibm:Notes0.500PercentDue2021Member
exch:XNYS 2020-12-24 2020-12-24 0000051143
ibm:Notes2.625PercentDue2022Member exch:XNYS 2020-12-24 2020-12-24
0000051143 ibm:Notes1.25PercentDue2023Member exch:XNYS 2020-12-24
2020-12-24 0000051143 ibm:Notes0.375PercentDue2023Member exch:XNYS
2020-12-24 2020-12-24 0000051143 ibm:Notes1.125PercentDue2024Member
exch:XNYS 2020-12-24 2020-12-24 0000051143
ibm:Notes2.875PercentDue2025Member exch:XNYS 2020-12-24 2020-12-24
0000051143 ibm:Notes0.950PercentDue2025Member exch:XNYS 2020-12-24
2020-12-24 0000051143 ibm:Notes0.875PercentDue2025Member exch:XNYS
2020-12-24 2020-12-24 0000051143 ibm:Notes0.300PercentDue2026Member
exch:XNYS 2020-12-24 2020-12-24 0000051143
ibm:Notes1.250PercentDue2027Member exch:XNYS 2020-12-24 2020-12-24
0000051143 ibm:Notes0.300PercentDue2028Member exch:XNYS 2020-12-24
2020-12-24 0000051143 ibm:Notes1.750PercentDue2028Member exch:XNYS
2020-12-24 2020-12-24 0000051143 ibm:Notes1.500PercentDue2029Member
exch:XNYS 2020-12-24 2020-12-24 0000051143
ibm:Notes1.750PercentDue2031Member exch:XNYS 2020-12-24 2020-12-24
0000051143 exch:XNYS ibm:Notes0.650PercentDue2032Member 2020-12-24
2020-12-24 0000051143 exch:XNYS ibm:Notes1.200PercentDie2040Member
2020-12-24 2020-12-24 0000051143
ibm:Debentures7.00PercentDue2025Member exch:XNYS 2020-12-24
2020-12-24 0000051143 ibm:Debentures6.22PercentDue2027Member
exch:XNYS 2020-12-24 2020-12-24 0000051143
ibm:Debentures6.50PercentDue2028Member exch:XNYS 2020-12-24
2020-12-24 0000051143 ibm:Debentures7.00PercentDue2045Member
exch:XNYS 2020-12-24 2020-12-24 0000051143
ibm:Debentures7.125PercentDue2096Member exch:XNYS 2020-12-24
2020-12-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
Title of
each class |
Capital stock, par value $.20 per
share |
Trading symbol |
IBM |
|
Common Stock |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report:
December 24, 2020
(Date of earliest event reported)
INTERNATIONAL BUSINESS MACHINES CORPORATION
(Exact name of registrant as specified in its charter)
New York |
|
001-02360 |
|
13-0871985 |
(State of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
One New Orchard Road
|
|
|
Armonk,
New York |
|
10504 |
(Address of principal executive offices) |
|
(Zip
Code) |
914-499-1900
(Registrant’s
telephone number)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425) |
|
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b)) |
|
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class |
|
Trading symbol |
|
Name of each exchange
on which registered |
Capital stock, par value $.20 per share |
|
IBM |
|
New
York Stock Exchange |
|
|
|
|
Chicago Stock
Exchange |
0.500% Notes due 2021 |
|
IBM 21B |
|
New
York Stock Exchange |
2.625% Notes due 2022 |
|
IBM 22A |
|
New
York Stock Exchange |
1.250% Notes due 2023 |
|
IBM 23A |
|
New
York Stock Exchange |
0.375% Notes due 2023 |
|
IBM 23B |
|
New
York Stock Exchange |
1.125% Notes due 2024 |
|
IBM 24A |
|
New
York Stock Exchange |
2.875% Notes due 2025 |
|
IBM 25A |
|
New
York Stock Exchange |
0.950% Notes due 2025 |
|
IBM 25B |
|
New
York Stock Exchange |
0.875% Notes due 2025 |
|
IBM 25C |
|
New
York Stock Exchange |
0.300% Notes due 2026 |
|
IBM 26B |
|
New
York Stock Exchange |
1.250% Notes due 2027 |
|
IBM 27B |
|
New
York Stock Exchange |
0.300% Notes due 2028 |
|
IBM 28B |
|
New York Stock Exchange |
1.750% Notes due 2028 |
|
IBM 28A |
|
New
York Stock Exchange |
1.500% Notes due 2029 |
|
IBM 29 |
|
New
York Stock Exchange |
1.750% Notes due 2031 |
|
IBM 31 |
|
New
York Stock Exchange |
0.650% Notes due 2032 |
|
IBM 32 |
|
New York Stock Exchange |
1.200% Notes due 2040 |
|
IBM 40 |
|
New York Stock Exchange |
7.00% Debentures due 2025 |
|
IBM 25 |
|
New
York Stock Exchange |
6.22% Debentures due 2027 |
|
IBM 27 |
|
New
York Stock Exchange |
6.50% Debentures due 2028 |
|
IBM 28 |
|
New
York Stock Exchange |
7.00% Debentures due 2045 |
|
IBM 45 |
|
New
York Stock Exchange |
7.125% Debentures due 2096 |
|
IBM 96 |
|
New
York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of
1934 (§240.12b-2
of this chapter).
Emerging growth company
¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ¨
Item 8.01. Other Events.
On December 24, 2020, IBM Credit LLC (“IBM Credit”), a wholly-owned
subsidiary of International Business Machines Corporation ("IBM"),
entered into a Receivables Purchase Agreement (the “Agreement”)
with Banco Santander S.A., pursuant to which IBM Credit may sell up
to $3 billion of its IBM short-term commercial financing
receivables at any one time, on a revolving basis. The transfers of
these receivables are expected to qualify as true sales and will
begin in December in the United States and Canada. Sales are
expected to expand to certain other countries through the first
half of 2021. The initial term of the Agreement is three years.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, hereunto duly authorized.
Date: December 31, 2020
|
|
|
|
|
|
By: |
/s/ Simon J.
Beaumont |
|
|
Simon J. Beaumont |
|
|
Vice
President and Treasurer |
|
|
|